AU7516098A - Immunomodulating, bile-derivable compositions for the treatment of viral disorders - Google Patents

Immunomodulating, bile-derivable compositions for the treatment of viral disorders

Info

Publication number
AU7516098A
AU7516098A AU75160/98A AU7516098A AU7516098A AU 7516098 A AU7516098 A AU 7516098A AU 75160/98 A AU75160/98 A AU 75160/98A AU 7516098 A AU7516098 A AU 7516098A AU 7516098 A AU7516098 A AU 7516098A
Authority
AU
Australia
Prior art keywords
immunomodulating
derivable
bile
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75160/98A
Inventor
Paul Percheson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aptose Bioscience Inc
Original Assignee
Imutec Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutec Pharma Inc filed Critical Imutec Pharma Inc
Publication of AU7516098A publication Critical patent/AU7516098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/413Gall bladder; Bile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU75160/98A 1997-05-23 1998-05-22 Immunomodulating, bile-derivable compositions for the treatment of viral disorders Abandoned AU7516098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002206047A CA2206047A1 (en) 1997-05-23 1997-05-23 Immunomodulating compositions for the treatment of viral disorders
CA2206047 1997-05-23
PCT/CA1998/000494 WO1998052585A1 (en) 1997-05-23 1998-05-22 Immunomodulating, bile-derivable compositions for the treatment of viral disorders

Publications (1)

Publication Number Publication Date
AU7516098A true AU7516098A (en) 1998-12-11

Family

ID=4160728

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75160/98A Abandoned AU7516098A (en) 1997-05-23 1998-05-22 Immunomodulating, bile-derivable compositions for the treatment of viral disorders

Country Status (3)

Country Link
AU (1) AU7516098A (en)
CA (1) CA2206047A1 (en)
WO (1) WO1998052585A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045727A2 (en) * 1999-12-20 2001-06-28 New Pharma Research Sweden Ab Stabilized veterinary compositions comprising more than one antiviral agent
WO2002038164A1 (en) 2000-11-08 2002-05-16 Lorus Therapeutics Inc. Combination preparation of a biological response modifier and an anticancer agent and uses thereof
ITRM20010688A1 (en) 2001-11-21 2003-05-21 Univ Roma IMMUNOREGULATORY COMPOUNDS.
CN115414370A (en) * 2022-10-14 2022-12-02 华中农业大学 Application of sodium taurocholate in preparing medicine for treating or preventing influenza virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE244570T1 (en) * 1993-09-09 2003-07-15 Lorus Therapeutics Inc IMMUNOMODULATING COMPOSITIONS FROM BIL
CN1108556A (en) * 1994-03-28 1995-09-20 李秀彩 Method for preparation of eyedrops
CN1114566A (en) * 1994-07-06 1996-01-10 云南滇东北制药总厂 Spray for preventing AIDS and VD and preparation method thereof
KR19980703088A (en) * 1995-03-16 1998-09-05 라카일레 지, 필리페 An inkjet recording paper comprising a new precipitated calcium carbonate pigment

Also Published As

Publication number Publication date
CA2206047A1 (en) 1998-11-23
WO1998052585A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU6513298A (en) Therapeutic compositions
AU6405198A (en) Plant for the treatment of products, which includes means for characterizing the products
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
AU2759800A (en) Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
HUP0004085A3 (en) Novel 3,6-hemiketals from the class of 9a-azalides
AU2021601A (en) Composition for the treatment of dandruff
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
HUP0003452A3 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
AU7516098A (en) Immunomodulating, bile-derivable compositions for the treatment of viral disorders
ZA982255B (en) Process for the preparation of arylmalonates.
AU686084B3 (en) Pharmaceutical compositions for the treatment of depressive disorders
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU6870500A (en) Process for the preparation of 2,3-dihydroazepine derivatives
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
AU5779998A (en) Process for the preparation of cyanoarylmethylamine
AU5982199A (en) Process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds
AU6281199A (en) Process for the preparation of cyclopropylacetylene
ZA986224B (en) Immunomodulating compositions for the treatment of viral disorders
AU2537200A (en) Atomizer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase